HRTX - Heron Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.33 0.02 (1.5%) --- --- 0.0 (0.0%) -0.01 (-0.75%) 0.02 (1.89%) 0.0 (0.0%) 0.0 (0.0%)

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.02
Diluted EPS:
-0.02
Basic P/E:
-67.5
Diluted P/E:
-67.5
RSI(14) 1m:
100.0
VWAP:
1.35
RVol:
0.562

Events

Period Kind Movement Occurred At
1m Price decrease 1m 1.31 -0.02 (-1.5%) Oct 15 09:36

Related News